KORU Medical : Investor Day 2023 Presentation

Forward Looking Statement

This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 regarding our expectations for future performance, including but not limited to the size of our target market, trends in macroeconomic healthcare spending (including the trend of moving healthcare from hospitals to homes), future revenues, expansion opportunities, progress in meeting Vision 2026 goals (including predicted future revenues, cash flows, and EBITDA margin), new patient starts, conversion of competitive users to the Company's prefilled system, the penetration in CIDP with PFS, the launch of a new pump and consumables platform, the generation of clinical evidence, the conversion of ePump systems, additional penetration in current markets, the geographic expansion into new markets, the use of pharmaceutical partners, future growth in the SCIg Market, claims related to the Freedom System, access to innovative pipeline positions, the projected growth of PFS, upcoming product launches, the extension into international markets (including projections that the Company will increase its internal revenue by 2X by 2026), trends in next generation technologies over existing products and services, timelines for novel therapy collaborations with the Company, expectations on launch dates, patient populations, infusions per year per patient, the total estimated infusions per year and the peak sales opportunity for the Company in those markets, recurring revenues in core business, future growth opportunities through novel therapies, increased gross margins, future investment decisions by the Company, and positive cash flows for the Company in the future. Forward-looking statements are neither historical facts nor assurances of future performance and based only on our current beliefs, expectations and assumptions. Forward-looking statements are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward- looking statements. Therefore, you should not rely on any of these forward-looking statements.​

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: new SCIg patient starts, growth of the SCIG market, plasma supply, clinical trial activity, market penetration of prefill syringes; supply chain and labor availability and pricing; third party contractor execution; timely receipt of other receivable credits; inflationary impacts; ability to reduce inventory; success of geographic expansion; effects of war and other global conflict; introduction of competitive products; availability of insurance reimbursement; changes in U.S. Food and Drug Administration regulations; changes to health care policies; success of our research and development efforts; our ability to obtain financing or raise capital if or when needed; acceptance of and demand for new and existing products; expanded market acceptance of the FREEDOM Syringe Infusion System and any new product we introduce; our ability to obtain required governmental approvals; success in enforcing and obtaining patents; continued performance by principal suppliers; continued customer preference to work through distributors; continued service of key personnel and attracting and maintaining new personnel; and general economic and business conditions, as well as those risks and uncertainties included under the captions "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 available on the SEC website at www.sec.gov[sec.gov] and on our website at www.korumedical.com/investors[korumedical.com]. Any forward-looking statement made by us is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Revenues: All references to revenue(s) in this presentation refer to net revenues.

2

1. OUR OPPORTUNITY
2. ACCELERATING OUR REVENUE GROWTH
3. DIFFERENTIATING OUR PRODUCT PORTFOLIO
4. VISION 2026 FINANCIAL GOALS

5

1. OUR OPPORTUNITY
2. ACCELERATING OUR REVENUE GROWTH
3. DIFFERENTIATING OUR PRODUCT PORTFOLIO
4. VISION 2026 FINANCIAL GOALS

10